Follow
Suzanne E. Lapi
Title
Cited by
Cited by
Year
The effects of Cu and Fe availability on the growth and Cu: C ratios of marine diatoms
AL Annett, S Lapi, TJ Ruth, MT Maldonado
Limnology and oceanography 53 (6), 2451-2461, 2008
1362008
[89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer
R Laforest, SE Lapi, R Oyama, R Bose, A Tabchy, BV Marquez-Nostra, ...
Molecular imaging and biology 18, 952-959, 2016
1262016
Assessment of an 18F-labeled phosphoramidate peptidomimetic as a new prostate-specific membrane antigen–targeted imaging agent for prostate cancer
SE Lapi, H Wahnishe, D Pham, LY Wu, JR Nedrow-Byers, T Liu, ...
Journal of Nuclear Medicine 50 (12), 2042-2048, 2009
1212009
Method for calibrating particle beam energy
J Publicover, S Lapi, T Ruth
US Patent App. 11/499,681, 2007
982007
Evaluation of 89Zr-pertuzumab in Breast Cancer Xenografts
BV Marquez, OF Ikotun, A Zheleznyak, B Wright, A Hari-Raj, RA Pierce, ...
Molecular pharmaceutics 11 (11), 3988-3995, 2014
862014
Cellular and whole-plant chloride dynamics in barley: insights into chloride–nitrogen interactions and salinity responses
DT Britto, TJ Ruth, S Lapi, HJ Kronzucker
Planta 218, 615-622, 2004
832004
Targeting HER2 in nuclear medicine for imaging and therapy
AVF Massicano, BV Marquez-Nostra, SE Lapi
Molecular Imaging 17, 1536012117745386, 2018
792018
89Zr-Radiolabeled Trastuzumab Imaging in Orthotopic and Metastatic Breast Tumors
AJ Chang, R DeSilva, S Jain, K Lears, B Rogers, S Lapi
Pharmaceuticals 5 (1), 79-93, 2012
762012
Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer
F Dehdashti, N Wu, R Bose, MJ Naughton, CX Ma, BV Marquez-Nostra, ...
Breast cancer research and treatment 169, 523-530, 2018
742018
Designing the magic bullet? The advancement of immuno-PET into clinical use
BD Wright, SE Lapi
Journal of Nuclear Medicine 54 (8), 1171-1174, 2013
732013
The impact of positron range on PET resolution, evaluated with phantoms and PHITS Monte Carlo simulations for conventional and non-conventional radionuclides
LM Carter, AL Kesner, EC Pratt, VA Sanders, AVF Massicano, CS Cutler, ...
Molecular imaging and biology 22, 73-84, 2020
712020
A semi-automated system for the routine production of copper-64
M Kume, PC Carey, G Gaehle, E Madrid, T Voller, W Margenau, MJ Welch, ...
Applied radiation and isotopes 70 (8), 1803-1806, 2012
712012
Development and characterization of 89Zr-labeled panitumumab for immuno–positron emission tomographic imaging of the epidermal growth factor receptor
AJ Chang, RA De Silva, SE Lapi
Molecular imaging 12 (1), 17, 2013
692013
Routine Production of 89Zr Using an Automated Module
AL Wooten, E Madrid, GD Schweitzer, LA Lawrence, E Mebrahtu, ...
Applied Sciences 3 (3), 593-613, 2013
672013
Production cross-sections of 181–186Re isotopes from proton bombardment of natural tungsten
S Lapi, WJ Mills, J Wilson, S McQuarrie, J Publicover, M Schueller, ...
Applied radiation and isotopes 65 (3), 345-349, 2007
672007
Citrullinated vimentin mediates development and progression of lung fibrosis
FJ Li, R Surolia, H Li, Z Wang, G Liu, T Kulkarni, AVF Massicano, ...
Science translational medicine 13 (585), eaba2927, 2021
652021
The rise of metal radionuclides in medical imaging: copper-64, zirconium-89 and yttrium-86
OF Ikotun, SE Lapi
Future Medicinal Chemistry 3 (5), 599-621, 2011
602011
Production of Zr-89 using sputtered yttrium coin targets
SL Queern, TA Aweda, AVF Massicano, NA Clanton, R El Sayed, ...
Nuclear medicine and biology 50, 11-16, 2017
592017
COPPER‐UPTAKE KINETICS OF COASTAL AND OCEANIC DIATOMS1
J Guo, AL Annett, RL Taylor, S Lapi, TJ Ruth, MT Maldonado
Journal of phycology 46 (6), 1218-1228, 2010
582010
Radiometals for imaging and theranostics, current production, and future perspectives
R Mikolajczak, NP van der Meulen, SE Lapi
Journal of Labelled Compounds and Radiopharmaceuticals 62 (10), 615-634, 2019
572019
The system can't perform the operation now. Try again later.
Articles 1–20